61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
GlaxoSmithKline PLC
Open
Sector Healthcare
1,308.5 0.31
Overview
Share price change
24h
Min
1301.5
Max
1314.5
Recommendations | Neutral |
|---|---|
12 Months Forecast | +27.56 upside |
Next Earnings | 5 Feb 2025 |
|---|---|
Next Dividend date | 9 Jan 2025 |
News Sentiment
By Acuity
51%
49%
325 / 392 Healthcare
GlaxoSmithKline PLC Chart
Past performance is not a reliable indicator of future results.
Related News
GlaxoSmithKline PLC Forecast
Price Target
By TipRanks
27.56% upside
12 Months Forecast
Average 1,662.73 GBX 27.56%
High 2,610 GBX
Low 1,350 GBX
Based on 13 Wall Street analysts offering 12 month price targets forGlaxoSmithKline PLC - Dist in the last 3 months.
Sentiment
By Acuity
325 / 392 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
$